Medies

MEDE | $0.51 0% 500

(0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (0.0% volume)
Earnings Calendar:
Market Cap: $ 3,399,915

Sec Filling | Patents | n/a employees

add to watch list Paper trade email alert is off

INMODE LTD.

INMD | $17.14 -1.55% -1.46% 990K

Health Technology

(0.0% 1d) (-16.2% 1m) (-54.6% 1y) (0.0% 2d) (0.0% 3d) (-1.8% 7d) (-36.91% volume)
Earnings Calendar: 2024-02-13
Market Cap: $ 1,439,459,399
http://www.inmodemd.com
Sec Filling | Patents | 251 employees

InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. It also designs, develops, manufactures and markets non-invasive medical aesthetic products that target a array of procedures including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture and superficial benign vascular and pigmented lesions. The company was founded by Moshe Mizrahy and Michael Kreindel on January 2, 2008 and is headquartered in Yokneam, Israel.

skin israel aesthetic treatment

add to watch list Paper trade email alert is off

PTC Therapeutics, Inc.

PTCT | News S | $25.97 2.57% 2.47% 650K

Health Technology

(0.0% 1d) (-10.0% 1m) (-50.9% 1y) (0.0% 2d) (0.0% 3d) (3.2% 7d) (-83.53% volume)
Earnings Calendar: 2024-02-29
Market Cap: $ 1,989,510,539
http://www.ptcbio.com
Sec Filling | Patents | 761 employees

(US) PTC Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and commercialization of clinically-differentiated medicines. It focuses on the development of new treatments for multiple therapeutic areas, including rare diseases and oncology. The company was founded by Allan Steven Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.

urea treatment